BREYNA 160 ug/1 (Budesonide and Formoterol Fumarate AEROSOL, METERED) 160 ug/1

Breyna 160 µg/1 is a metered aerosol containing Budesonide and Formoterol Fumarate, designed for respiratory inhalation. This combination medication is commonly used for managing asthma and chronic obstructive pulmonary disease (COPD).

Strength

160 ug/1

Pack Size

1 POUCH in 1 CARTON (0378-7503-32) / 1 CANISTER in 1 POUCH / 120 AEROSOL, METERED in 1 CANISTER

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Breyna 160 µg/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines Budesonide, a corticosteroid, and Formoterol Fumarate, a long-acting beta-agonist, to reduce inflammation and relax airway muscles. This medication is often prescribed to improve breathing and prevent symptoms such as wheezing and shortness of breath. Patients may wonder, 'What is Breyna 160 µg/1 used for?' It is typically used as a long-term control medication rather than for immediate relief of acute symptoms.

Side Effects

Common effects of Breyna 160 µg/1 may include throat irritation, hoarseness, and a dry mouth. Some users might experience headaches, tremors, or an increased heart rate. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Precautions & Warnings

Breyna 160 µg/1 should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to reduce the risk of oral thrush. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their use of this medication with their healthcare provider. Always store the aerosol canister upright and away from heat and flame.

Avoid Interactions

Breyna 160 µg/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking. Consuming alcohol while using this medication may increase the risk of side effects. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

Breyna 160 µg/1 is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Store the aerosol canister upright and away from heat and flame. Keep it in a cool, dry place.

Common effects may include throat irritation, hoarseness, dry mouth, headaches, tremors, and an increased heart rate.

No, Breyna 160 µg/1 is a maintenance medication and not intended for immediate relief of acute symptoms.

If you experience severe or persistent side effects, consult a healthcare provider immediately.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.